Biotechnology: Class 12 — Chapter 1: An Overview of Recombinant DNA Technology

• rDNA Technology: The collection of techniques used to directly manipulate the genome/nucleic acids of an organism to alter its genetic makeup.
• Gene Cloning: The fundamental theme of rDNA technology involving the isolation and propagation of a desired DNA molecule (gene) from a source to obtain its product in ample quantity.
• Key Milestones: Isolation and purification of nucleic acids, determination of the double-helical structure of DNA, and understanding the central dogma processes (replication, transcription, and translation).

Traditional genetic manipulation was limited by species barriers, preventing the precise transfer of individual functional genes between unrelated organisms.

---

Engineering Methodology & Mechanism: In 1973, Stanley Cohen (expert in introducing plasmid DNA into Escherichia coli) and Herbert Boyer (expert in cleaving double-stranded DNA with restriction enzymes to produce cohesive, single-stranded termini) combined their methodologies. They cut open a plasmid loop from one bacterial species, inserted a foreign gene from a different species, and sealed the loop to create the first functional recombinant plasmid, yielding the world's first genetically modified organism.

• Restriction Enzymes: Discovered by Werner Arber, Hamilton Smith, and Daniel Nathans (late 1960s–early 1970s). These act as molecular scissors to cut DNA molecules at specific target sequences.
• DNA Ligase: Discovered by Gellert, Lehman, Richardson, and Hurwitz (1967). This enzyme acts as molecular glue to covalently join two DNA fragments together.
• Plasmids: Discovered by Joshua Lederberg (1952). These are extrachromosomal, self-replicating circular DNA molecules used as vectors to carry foreign genetic material into host cells.

• Insulin (Humulin): Historically, obtaining insulin required processing tons of animal pancreatic glands, which was expensive, limited in yield, and caused immunogenic allergic reactions in humans. rDNA technology enabled the expression of pure human insulin in bacterial systems.
• Human Growth Hormone: Previously extracted in minute quantities from human cadaver pituitary glands to treat dwarfism; now safely synthesized via recombinant bacterial systems.
• Interferons: Produced recombinantly to assist in cancer therapies and viral infections.
• Clot-Dissolving Enzymes: Recombinant plasminogen activator and urokinase are synthesized to dissolve coronary blood clots.

• Genetically Modified (GM) Crops: Developed by introducing targeted modifications into plant genomes to confer resistance to pests, diseases, and environmental stresses.
• Abiotic Stress Tolerance: Engineering crops capable of surviving drought, high salinity, and extreme temperatures to ensure food security in adverse environments.
• Molecular Farming: The emerging field of using plants as bioreactors to produce therapeutic proteins, peptides, and hormones, offering cost-effective and contamination-free alternatives to animal-based production systems.